news.cision.com

Lund, Sweden, January 19, 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that an abstract with novel preclinical cancer data related to the company’s sanglifehrin-based compounds has been accepted for presentation at the scientific conference EASL HCC Summit to take place in Geneva, Switzerland, 2-5 February, 2017.NeuroVive has utilized its expertise in mitochondrial medicine to explore a unique aspect of the company’s sanglifehrin-based compounds.

Invitation to press and analyst conference – Q4 2016

BillerudKorsnäs’ Year-end Report for January-December 2016 will be published on Thursday2 February at approximately 07.00 CET. At 10.00 CET on the same day, Per Lindberg, President and CEO, and Susanne Lithander, CFO, will present the Year-end Report at a press and analyst conference. The presentation will be held in English and will be followed by a Q&A session. The presentation material will be available at BillerudKorsnäs’ website. Venue: Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm To participate, please e-mail Karin.slattborn@billerudkorsnas.com or call +46 8 553

Invitation to the news conferences on Fortum's 2016 Financial Statements Bulletin on 2 February 2017

FORTUM CORPORATION STOCK EXCHANGE RELEASE 19 JANUARY 2017 AT 11.00 EET Fortum will publish its 2016 Financial Statements Bulletin on Thursday 2 February at approximately 9.00 EET. Press conference for media A news conference in Finnish for media will be arranged at 12.00 EET at Fortum’s headquarters, Keilaniementie 1, Espoo, Finland. On arrival, members of the media are requested to show their press card and photo ID. Lunch will be served at the event and there will not be a webcast. Webcast/teleconference for analysts and investors An international teleconference and live

UPM BioVerno and GrowDex® chosen among 25 unique example cases of Nordic bioeconomy

Thu, Jan 19, 2017 09:34 CET

(UPM, 19 January 2017 at 11:00 EET) - The Nordic Bioeconomy Panel under The Nordic Council of Ministers has chosen UPM BioVerno and GrowDex® in the Nordic bioeconomy - 25 cases for sustainable change catalogue. UPM BioVerno is a renewable diesel made of crude tall oil, a wood residue from pulp production. GrowDex® is a wood-based nanocellulose hydrogel developed for the needs of the pharmaceutical industry. "The Nordic countries are strongly placed to be global leaders in the production and utilisation of bio-resources that will enhance both competitiveness and sustainability.

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

A new research article, with lead authors from the University of Gothenburg, gives indications of the best places in Iceland to build thermal power stations.In Iceland, heat is extracted for use in power plants directly from the ground in volcanic areas. Constructing a geothermal power station near a volcano can be beneficial, since Earth’s mantle is located relatively close to the crust in those areas, making the heat easily accessible. This means that the boreholes do not need to be very deep and the pipes to the power plant can be short. But placing a power plant near an active

Invitation to conference call and webcast presentation of Metsä Board's Financial statements bulletin 2016 on 2 February 2017

Thu, Jan 19, 2017 09:15 CET

Metsä Board Corporation Investor News 19 January 2017 at 10.15 EET Metsä Board will publish its Financial statements bulletin 2016 on Thursday, 2 February 2017 at 12:00 EET. We are pleased to invite you to join conference call and webcast presentation on the same day at 3:00 p.m. EET. Conference call will be held in English. Participants are requested to call in and register a few minutes prior to the start of the conference call on the following numbers: Finland: +358 (0)9 7479 0361 Sweden: +46 (0)8 5033 6574 UK: +44 (0)330 336 9105 US: +1 719-457-1036 The conference

Q4 and full year 2016 results conference call

MTG will publish its Q4 and full year 2016 financial results at 07:30 CET on Thursday 2 February, and will hold a conference call at 09:00 CET the same day. The call will be hosted by Jørgen Madsen Lindemann (President & CEO) and Maria Redin (CFO).To participate, please dial: Sweden: +46(0)8 5033 6574UK: +44(0)330 336 9412US: +1719 325 2213 The access pin code for the call is 8491480 To ensure that the conference call starts on time, please dial in 5-10 minutes before the scheduled start time. The conference call will also be available live but in ‘listen-only’ mode at mtg.

First patients enrolled in 24 month real-world study evaluating effectiveness of Elocta®

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the first patients have been enrolled in the A-SURE study (NCT02976753). A-SURE is a 24-month real-world study evaluating the effectiveness of Elocta® compared to conventional FVIII products in the prophylactic treatment of patients with haemophilia A in Europe. The efficacy and safety of Elocta have been established in clinical trials and the A-SURE study will provide data from a real-world setting, which can be made available to physicians, payers and reimbursement authorities in evaluating the

Announcement of the NAV of proventus capital partners iii

Today the Net Asset Value of the Proventus Capital Partners III participation loans is being announced. At the close of business on 18 January, the Net Asset Value of the series A participation loan debentures amounted to SEK 899,897 each, and the Net Asset Value of the series B participation loan debenture amounted to SEK. 22,646,830 each.The Net Asset Value of Proventus Capital Partners III participation loan is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value has been set as a result of Proventus Capital Partners

Andrew Gilbert appointed as new Chairman for Wirepas

Wirepas, a global device connectivity provider, has appointed Andrew Gilbert as the new chairman and Jörgen Lantto as a new member of its Board of Directors. Vesa Laisi has been appointed as a new advisor to the board. Sami Lampinen (managing partner, Inventure), Carl-Erik Mattila (partner, Topnet), Teppo Hemiä (CEO, Wirepas) and Patrick Sheehan (managing partner, ETF Partners) have been reappointed as members of the board. Benedikt Herles (managing partner, Vito Ventures) has been reappointed as a board observer. “Wirepas has uniquely solved, what I believe to be, one of the biggest

Mr Green crowned Nordic Operator of the Year 2017

On Tuesday 17 January Mr Green was officially announced the winner of the titles, ‘Nordic Operator of the Year’ and ‘Marketing Campaign of the Year’, by the industry publisher EGR (eGaming Review magazine).The awards are a recognition of Mr Green’s focus on entertaining its players, based upon a unique customer journey, beginning from marketing communication through to the gaming experience in their casino and sports betting products. Mr Green had, just two months earlier been awarded the EGR title ‘Mobile Casino Operator of the Year 2016’. Adding ‘Nordic Operator of the Year 2017’ to

Höegh LNG - Contemplating issuing unsecured bonds

Thu, Jan 19, 2017 08:53 CET

Hamilton, Bermuda 19 January 2017 - Höegh LNG Holdings Ltd. is contemplating the issuance of senior unsecured bonds in the Norwegian bond market with maturity in February 2022. The net proceeds from the contemplated bond issue shall be used for the part refinancing of the bond issue with ticker HLNG01 (ISIN: NO001066095.4) and general corporate purposes. Danske Bank Markets, DNB Markets and Nordea are engaged as joint lead managers for the bond issue. * * * About Höegh LNG: Höegh LNG provides floating energy solutions and operates world-wide with a leading position as owner

Invitation - SEB's Annual Accounts 2016

SEB's result for the Annual Accounts 2016 will be announced on Wednesday, 1 February, at 07:00 (Swedish time).In addition, presentations and the Fact Book will be available on www.sebgroup.com/ir. You are invited to participate in the following presentations. Wednesday, 1 FebruaryPress conferenceTime: 09:30 (Swedish time)Venue: Kungsträdgårdsgatan 8, StockholmAnnika Falkengren, President and CEO, will present and comment upon the results. Please note that the presentation will be conducted in Swedish. The press conference can be followed live on www.sebgroup.com/ir and

Nel ASA: Signs joint venture LoI with PowerCell and Hexagon Composites

Thu, Jan 19, 2017 08:45 CET

(Oslo, 19 January 2017) Nel ASA (Nel) announced today that the company has entered into Letter of Intent (LoI) with Hexagon Composites ASA and PowerCell Sweden AB to establish a joint venture (JV) for the development of integrated hydrogen projects. The joint venture will initially focus on opportunities in the maritime and marine segments as well as projects to leverage renewable energy resources. ”We are pleased to announce that we are joining forces with PowerCell and Hexagon Composites to establish a JV for the development of integrated hydrogen solutions and projects. This

PowerCell, Hexagon Composites and Nel have signed a Letter of Intent

Thu, Jan 19, 2017 08:45 CET

The leading fuel cell company PowerCell Sweden AB (publ) has signed a Letter of Intent together with Hexagon Composites ASA and Nel ASA, both companies from Norway, to establish a joint venture.PowerCell, Hexagon Composites and Nel intend to establish a joint venture that will enable project development together with customers. The parties intend to stimulate and develop projects where each party's respective technologies and competences are utilized. Hexagon Composites ASA is a global market leader for storage and transport of gases under high pressure and Nel

Hexagon Composites signs Letter of Intent with Nel and PowerCell

Thu, Jan 19, 2017 08:45 CET

Hexagon Composites ASA (OSE:HEX ) has signed a Letter of Intent (LoI) with Nel ASA and PowerCell Sweden AB to establish an equally owned joint venture to pursue hydrogen opportunities. The Parties aim at leveraging their respective capabilities and technologies to offer integrated solutions. The joint venture will initially focus on opportunities in the maritime and marine segments as well as projects to leverage renewable energy resources. "This is an important step in our commitment to develop clean energy alternatives,"

New Business Development Director at AcadeMedia

Kristofer Hammar, who has worked for AcadeMedia for eight years, will assume a newly created position as Business Development Director at AcadeMedia on February 1. From this date he will also be a member of the Group Management Committee.Kristofer Hammar has until now worked with business development, AcadeMedia's acquisitions and international expansion. “Kristofer will be an important addition to AcadeMedia’s Group Management Committee. His experience within the organization and his work with our international expansion has been very successful and I look forward to working more

Eva Fraenkel new CMO at Rapunzel of Sweden

In order to further strengthen and develop the company towards our ambitious targets Rapunzel of Sweden have recruited Eva Fraenkel as new Chief Marketing Officer.The recruiting of Eva Fraenkel to Rapunzel of Sweden secures additional expertise to further develop the company's international expansion. Eva will be responsible for the company's marketing of both e-commerce and the salon business and comes from a position as Marketing Director at Gudrun Sjödén where she worked with their successful international expansion. Previously, Eva held senior positions in companies Indiska, Åhléns and

Sprint Bioscience builds on its strengths - with biology in focus

Sprint Bioscience further strengthens its resources with an industrial graduate student and a scientific collaboration with the Luxembourg Institute of Health (LIH). Autophagy is a process that breaks down defective or damaged cellular components and is used by cancer cells to enhance their ability to survive and grow. Autophagy plays a central role in the development of resistance to chemotherapy and other cancer therapies. Vps34 is a key protein in the initiation of autophagy and Sprint Bioscience is running a pharmaceutical project aiming to combat cancer by inhibiting Vps34.

Combitech awarded a contract for D-ATIS and ATIS to the four busiest airports in Sweden

Following a competitive tender process, Swedavia has contracted Combitech, part of the defence and security group Saab AB, for the supply of Digital Automated Terminal Information Service System (D-ATIS) and ATIS to Stockholm Arlanda, Stockholm Bromma, Göteborg Landvetter and Malmö Sturup.The contract also includes an option for the supply of D-ATIS and ATIS to four additional airports. “The contract is in my opinion further evidence that Combitech is the leading provider of weather information systems for the aviation market", says Magnus Johansson, Head of System Integration and

Atlas Copco has agreed to divest its road construction equipment business